Closed-loop glucose control: Psychological and behavioral considerations

Journal of Diabetes Science and Technology

Volumn 5, Issue 6, 2011, Pages 1387-1395

  Gonder Frederick, Linda ^a   Shepard, Jaclyn ^a   Peterson, Ninoska ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adoption and utilization; Artificial pancreas; Behavioral factors; Closed loop glucose control; Diabetes technology

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTIFICIAL PANCREAS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; REVIEW; UTILIZATION REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PANCREAS, ARTIFICIAL; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 84862690292     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500610     Document Type: Conference Paper

References (75)

1. Kovatchev B. Closed loop control for type 1 diabetes. BMJ. 2011;342:d1911.
2. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ. 2011;342:1855.
3. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet. 2010;375(9716):743-51.
4. Elleri D, Acerini CL, Allen JM, Hayes J, Pesterfield C, Wilinska ME, Dunger DB, Hovorka R. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. Diabetes Technol Ther. 2010;12(1):35-9.
5. Van Bon AC, Brouwer TB, von Basum G, Hoekstra JB, DeVries JH. Future acceptance of an artificial pancreas in adults with type 1 diabetes. Diabetes Technol Ther. 2011;13(7):731-6.
6. Chase HP, Beck RW, Xing D, Tamborlane WV, Coffey J, Fox LA, Ives B, Keady J, Kollman C, Laffel L, Ruedy KJ. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther. 2010;12(7):507-15.
7. Garg, SK. Impact of insulin delivery devices in diabetes care. Diabetes Technol Ther. 2010;12 Suppl 1:S1-3.
8. Medtronic. Questions and answers about pump therapy. Available from: http://wwwp.medtronic.com/Newsroom/. Accessed July 12, 2011.
9. Maahs DM, Horton LA, Chase HP. The use of insulin pumps in youth with type 1 diabetes. Diabetes Technol Ther. 2010;12 Suppl 1:S59-65.
10. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13 Suppl 1:1-68.
11. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F; European Society for Paediatric Endocrinology; Lawson Wilkins Pediatric Endocrine Society; International Society for Pediatric and Adolescent Diabetes; American Diabetes Association; European Association for the Study of Diabetes. Use of insulin pump therapy in the paediatric age group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2007;30(6):1653-62.
12. Tsalikian E, Mauras N, Beck RW, Tamborlane WV, Janz KF, Chase HP, Wysocki T, Weinzimer SA, Buckingham BA, Kollman C, Xing D, Ruedy KJ; Diabetes Research In Children Network Direcnet Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr. 2005;147(4):528-34. (Pubitemid 41446549)
13. Garg SK, Walker AJ, Hoff HK, D'Souza AO, Gottleib PA, Chase HP. Glycemic parameters with multiple daily injections using glargine versus insulin pump. Diabetes Technol Ther. 2004;6(1):9-15. (Pubitemid 38233740)
14. Wu YP, Graves MM, Roberts MC, Mitchell AC. Is insulin pump therapy better than injection for adolescents with diabetes? Diabetes Res Clin Pract. 2010;89(2):121-5.
15. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26(4):1079-87. (Pubitemid 36929252)
16. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25(7):765-74.
17. Babar GS, Ali O, Parton EA, Hoffmann RG, Alemzadeh R. Factors associated with adherence to continuous subcutaneous insulin infusion in pediatric diabetes. Diabetes Technol Ther. 2009;11(3):131-7.
18. De Vries L, Grushka Y, Lebenthal Y, Shalitin S, Phillip M. Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes. Pediatr Diabetes. 2011;12(5):506-12.
19. Guinn TS, Bailey GJ, Mecklenburg RS. Factors related to discontinuation of subcutaneous insulin-infusion therapy. Diabetes Care. 1988;11(1):46-51.
20. Ronsin O, Jannot-Lamotte MF, Vague P, Lassman-Vague V. Factors related to CSII compliance. Diabetes Metab. 2005;31(1):90-5. (Pubitemid 40327599)
21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
22. Stephens EA, Heffner J. Evaluating older patients with diabetes for insulin pump therapy. Diabetes Technol Ther. 2010;12 Suppl 1:S91-7.
23. Jornsay DL, Duckles AE, Hankinson JP. Psychological considerations for patient selection and adjustment to insulin pump therapy. Diabetes Educ. 1988;14(4):291-6.
24. American Diabetes Association. Continuous subcutaneous insulin infusion. Diabetes Care. 2004;27 Suppl 1:S110.
25. American Association of Diabetes Educators. AADE Position Statement: Continuous subcutaneous insulin therapy using a pump. Diabetes Educ. 2009.
26. Cortina S, Repaske DR, Hood KK. Sociodemographic and psychological factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes. Pediatr Diabetes. 2010;11(5):337-44.
27. O'Connell MA, Cameron FJ. Practical experience with continuous subcutaneous insulin infusion therapy in a pediatric diabetes clinic. J Diabetes Sci Technol. 2008;2(1):91-7.
28. Eugster EA, Francis G, Lawson-Wilkins Drug and Therapeutics Committee. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatr. 2006;118(4):e1244-9. (Pubitemid 46393819)
29. Lenhard MJ, Grafton D, Reeves MD. Continuous subcutaneous insulin infusion. A comprehensive review of insulin pump therapy. Arch Intern Med. 2001;161(19):2293-300. (Pubitemid 32980127)
30. Wysocki T, Harris MA, Wilkinson K, Sadler M, Mauras N, White NH. Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes. Diabetes Care. 2003;26(7):2043-7. (Pubitemid 41184249)
31. Cogen FR, Streisand R, Sarin S. Selecting children and adolescents for insulin pump therapy: Medical and behavioral considerations. Diabetes Spectr. 2002;15(2):72-5.
32. Pham M. Diabetes: Updated survey on insulin pumps and continuous glucose monitoring. New York, NY: HSBC Securities (USA) Inc; 2006 Aug.
33. Pham M, Phung V. Diabetes: Updated survey on insulin pumps and continuous glucose monitoring. New York, NY: HSBC Securities (USA) Inc; 2007 Jul.
34. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009;32(11):1947-53.
35. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care. 2010;33(1):17-22.
36. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730-2. (Pubitemid 44912209)
37. Garg SK, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29(1):44-50. (Pubitemid 44033429)
38. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomized controlled trials using individual patient data. BMJ. 2011;343:d3805.
39. Diabetes Research in Children Network (DirecNet) Study Group. Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes. Pediatr Diabetes. 2006;7(1):32-8.
40. Kashmer L, Clarke W, Gurka M, Elchuri S, Nyer M, Gonder- Frederick L. Predictors of parental interest in continuous glucose monitoring for children with type 1 diabetes. Diabetes Technol Ther. 2009;11(6):373-8.
41. Ritholz M. Is continuous glucose monitoring for everyone? Consideration of psychosocial factors. Diabetes Spectr. 2008;21(4):287-9.
42. Block JM, Buckingham B: Use of real-time continuous glucose monitoring technology in children and adolescents. Diabetes Spectr. 2008;21(2):84-90. (Pubitemid 351792951)
43. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-76.
44. Ritholz MD, Atakov-Castillo A, Beste M, Beverly EA, Leighton A, Weinger K, Wolpert H. Psychosocial factors associated with use of continuous glucose monitoring. Diabet Med. 2010;27(9):1060-5.
45. Chase HP, Messer L. Understanding insulin pumps and continuous glucose monitors. 2nd ed. Denver, CO: Children's Diabetes Foundation; 2010. p. 93-6.
46. Hirsch IB. Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist. J Clin Endocrinol Metab. 2009;94(7):2232-8.
47. Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K; Diabetes Research in Children Network (DirecNet) Study Group. Freestyle Navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: Results of a pilot trial. Diabetes Care. 2008;31(3):525-7.
48. Evert A, Trence D, Catton S, Huynh P. Continuous glucose monitoring technology for personal use: an educational program that educates and supports the patient. Diabetes Educ. 2009;35(4):565-7, 571-3, 577-80.
49. Fabiato K, Buse J, Duclos M, Largay J, Izlar C, O'Connell T, Stallings J, Dungan K. Clinical experience with continuous glucose monitoring in adults. Diabetes Technol Ther. 2009;11 Suppl 1:S93-S103.
50. Wadwa RP, Fiallo-Scharer R, Vanderwel B, Messer LH, Cobry E, Chase HP. Continuous glucose monitoring in youth with type 1 diabetes. Diabetes Technol Ther. 2009;11 Suppl 1:S83-91.
51. Scaramuzza AE, Iafusco D, Rabbone I, Bonfanti R, Lombardo F, Schiaffini R, Buono P, Toni S, Cherubini V, Zuccotti GV; Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study. Diabetes Technol Ther. 2011;13(2):99-103.
52. Fisher LK, Halvorson M. Future developments in insulin pump therapy: progression from continuous subcutaneous insulin infusion to a sensor-pump system. Diabetes Educ. 2006;32(1 Suppl):47S-52S. (Pubitemid 43206842)
53. Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia. 2010;53(12):2487-95.
54. Conget I, Battelino T, Giménez M, Gough H, Castañeda J, Bolinder J; SWITCH Study Group. The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensoraugmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy. Diabetes Technol Ther. 2011;13(1):49-54.
55. Peyrot M, Rubin RR. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system. Diabetes Technol Ther. 2009;11(1):57-62.
56. Halvorson M, Capenter S, Kaiserman K, Kaufman FR. A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump. J Pediatr. 2007;150(1):103-105.e1.
57. Garg SK, Voelmle MK, Beatson CR, Miller HA, Crew LB, Freson BG, Hazenfield RM. Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study. Diabetes Care. 2011;34(3):574-9.
58. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-20.
59. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther. 2008;10(5):377-83.
60. Rubin R, Borgman SK, Sulik BT. Crossing the technology divide: Practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy. Diabetes Educ. 2011;37 Suppl 1:5S-18S; quiz 19S-20S.
61. Reach G. Can technology improve adherence to long-term therapies? J Diabetes Sci Technol. 2009;3(3):492-9.
62. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11(1):1-47.
63. Ajzen, I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211.
64. Rogers EM. Diffusion of innovations. 4th ed. New York: The Free Press; 1995.
65. Reach G. Role of habit in adherence to medical treatment. Diabet Med. 2005;22(4):415-20. (Pubitemid 40516240)
66. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15(2):175-83.
67. Gonder-Frederick L, Schmidt KM, Vajda KA, Greear ML, Singh H, Shepard JA, Cox DJ. Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes mellitus. Diabetes Care. 2011;34(4):801-6.
68. Hood KK, Butler DA, Volkening LK, Anderson BJ, Laffel LM. The Blood Glucose Monitoring Communication questionnaire: an instrument to measure affect specific to blood glucose monitoring. Diabetes Care. 2004;27(11):2610-5. (Pubitemid 39441459)
69. Sharifirad G, Hazavehi MM, Baghianimoghadam MH, Mohebi S. The effect of a Health Belief Model based education program for foot care in diabetic patients type II in Kermanshah, Iran (2005). Int J Endocrinol Metab. 2007;5(2):82-90.
70. Bond GG, Aiken LS, Somerville SC. The health belief model and adolescents with insulin-dependent diabetes mellitus. Health Psychol. 1992;11(3):190-8.
71. Cerkoney KA, Hart LK. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care. 1980;3(5):594-8. (Pubitemid 11245824)
72. Wdowik MJ, Kendall PA, Harris MA, Auld G. Expanded health belief model predicts diabetes self-management in college students. J Nutr Educ. 2001;22(1):17-23.
73. Gillibrand R, Stevenson J. The extended health belief model applied to the experience of diabetes in young people. J Health Psychol. 2006;11(Pt 1):155-69. (Pubitemid 43333372)
74. Omondi DO, Walingo MK, Mbagaya GM, Othuon LOA. Understanding physical activity behavior of type 2 diabetics using the theory of planned behavior and structural equation modeling. Int J Hum Social Sci. 2010;5(3):160-7.
75. Rogers EM. A prospective and retrospective look at the diffusion model. J Health Commun. 2004;9 Suppl 1:13-9. (Pubitemid 38367015)